Lakewood-Amedex Biotherapeutics Secures Composition of Matter Patent Protecting New Bisphosphocin® Compounds Being Developed for High-Need Antimicrobial Infections

Go back to Lakewood-Amedex Biotherapeutics Secures Composition of Matter Patent Protecting New Bisphosphocin® Compounds Being Developed for High-Need Antimicrobial Infections
(NASDAQ: LABT) Delayed: 1.99 +0.13 (6.99%)
Previous Close $1.86    52 Week High
Open $1.92    52 Week Low
Day High $2.15    P/E N/A 
Day Low $1.89    EPS
Volume 287,863